Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 1,424 followers.

RT @JournalofExper1: New! 📌 #𝐑𝐞𝐠𝐨𝐫𝐚𝐟𝐞𝐧𝐢𝐛 enhances 𝐚𝐧𝐭𝐢-#𝐏𝐃𝟏 #𝐢𝐦𝐦𝐮𝐧𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 in 𝐦𝐮𝐫𝐢𝐧𝐞 #𝐜𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥𝐜𝐚𝐧𝐜𝐞𝐫𝐬 and their combination pre…

Reply Repost Favourite

New! 📌 #𝐑𝐞𝐠𝐨𝐫𝐚𝐟𝐞𝐧𝐢𝐛 enhances 𝐚𝐧𝐭𝐢-#𝐏𝐃𝟏 #𝐢𝐦𝐦𝐮𝐧𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 in 𝐦𝐮𝐫𝐢𝐧𝐞 #𝐜𝐨𝐥𝐨𝐫𝐞𝐜𝐭𝐚𝐥𝐜𝐚𝐧𝐜𝐞𝐫𝐬 and their combination prevents 𝐭𝐮𝐦𝐨𝐫 𝐫𝐞𝐠𝐫𝐨𝐰𝐭𝐡 For free 💻 https://t.co/sc8jxX91dD @IREISGufficiale https://t.co/4maOu2ooLl

Reply Repost Favourite

New article: Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth https://t.co/Q1tEWD7eSu #colorectalcancer #oncology https://t.co/UEEiwjAmoL

Reply Repost Favourite

New article: Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth https://t.co/kLospPHavb #livercancer #oncology https://t.co/ekV7EST5sm

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.